跳至主要内容
临床试验/CTRI/2021/02/031395
CTRI/2021/02/031395招募中1 期

A randomized controlled clinical study to evaluate the efficacy of madhu kumari lepa in management of periorbital hyperpigmentation

purva verma self0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.subjects diagnosed with periorbital hyperpigmentation will be included
  • 2.subjects of age group 21 to 50 years will be included irrespective of their gender ,religion,and socio economic status
  • 3.subjects who are willing to participate in the study
  • 4.subjects with periorbital hyperpigmentation caused due to constitutional causes

排除标准

  • 1.subjects taking photosensitizing drugs like NASIDS,anti -histamines,oral contraceptives,sulphonamides etc
  • 2.Chloasma/melasma,post -inflammatory hyperpigmentation will be excluded
  • 3.smoking ,alcoholism
  • 5.subjects suffering from any other systemic illness

研究者

发起方
purva verma self

相似试验